文献速递肝病

肠道病毒组与噬菌体在肝病中的治疗潜力

Intestinal virome and therapeutic potential of bacteriophages in liver disease.
PubMed 文献 · J Hepatol · 2021-08-24

本文综述了肠道病毒组在肝病中的变化及噬菌体疗法的潜力。人类肠道中噬菌体和真核病毒数量超过细菌和真菌,但肝病患者的肠道病毒组研究较少。噬菌体作为细菌天然捕食者,可精准编辑细菌微生物群,靶向肝病相关细菌致病共生菌。文章总结了脂肪肝病和肝硬化相关的粪便病毒组变化,并描述了噬菌体的治疗潜力及临床应用面临的挑战。

要点

  • 肝病患者肠道病毒组研究较少,噬菌体可精准靶向细菌致病共生菌。
  • 粪便病毒组变化与脂肪肝病和肝硬化相关。
  • 噬菌体疗法在肝病中具治疗潜力,但临床应用面临挑战。

核心结论

  • 噬菌体作为细菌天然捕食者,可精准编辑肠道细菌微生物群,有望靶向肝病相关细菌致病共生菌。

研究设计与样本

  • 本文为综述,总结了肝病相关粪便病毒组变化及噬菌体治疗潜力与挑战。

主要发现

  • 人类肠道中噬菌体和真核病毒数量超过细菌和真菌。
  • 肝病患者肠道病毒组研究较少。
  • 粪便病毒组变化与脂肪肝病和肝硬化相关。

临床怎么用

  • 噬菌体疗法可能用于靶向肝病相关细菌致病共生菌,但临床应用于肝病尚需克服挑战。

局限性

  • 肝病患者肠道病毒组研究较少,噬菌体临床应用存在挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Humans harbour a large quantity of microbes in the intestinal tract and have evolved symbiotic relationships with many of them. However, several specific bacterial pathobionts are associated with liver disease pathogenesis. Although bacteriophages (phages) and eukaryotic viruses (collectively known as "the virome") outnumber bacteria and fungi in the intestine, little is known about the intestinal virome in patients with liver disease. As natural predators of bacteria, phages can precisely edit the bacterial microbiota. Hence, there is interest in using them to target bacterial pathobionts in several diseases, including those of the liver. Herein, we will summarise changes in the faecal virome associated with fatty liver diseases and cirrhosis, and describe the therapeutic potential of phages and potential challenges to their clinical application.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Hsu CL, Duan Y, Fouts DE, et al. Intestinal virome and therapeutic potential of bacteriophages in liver disease. J Hepatol. 2021. PMID: 34437908. doi:10.1016/j.jhep.2021.08.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。